Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 70/100

Multiple RAD301 data releases to be presented at EMIM

Wednesday, March 6, 2024 1 min read
Key Takeaway: Radiopharm Theranostics is set to present multiple data releases related to RAD301 at the upcoming EMIM event. This follows a series of positive clinical updates across their programs, showcasing the company's progress in the biopharma sector. The presentations are expected to provide insights into their ongoing clinical studies and future directions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Multiple data releases indicate ongoing progress in clinical studies.
  • Presentation at EMIM highlights the company's commitment to transparency.
  • Positive clinical updates suggest advancements in their therapeutic programs.

Full Press Release Details

• Announcements
• March 6, 2024
Loading Viewer…

More Announcements & Updates

• Announcements
• November 23, 2021
• Announcements
• November 29, 2021
• Announcements
• March 1, 2024
• Announcements
• December 13, 2021

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What is RAD301?

RAD301 is a therapeutic program by Radiopharm Theranostics currently in clinical development.

When will the RAD301 data be presented?

The RAD301 data will be presented at the upcoming EMIM event.

What updates has Radiopharm provided recently?

Radiopharm has shared positive clinical updates across several of its therapeutic programs.

What is the significance of the EMIM presentation?

The EMIM presentation highlights Radiopharm's commitment to transparency and progress in clinical studies.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm Theranostics RAD301 EMIM clinical updates biopharma
Last updated: Mar 6, 2024